Challenges in The Management of Hypertension in Asia: Bernard Man Yung Cheung and Tommy Tsang Cheung
Challenges in The Management of Hypertension in Asia: Bernard Man Yung Cheung and Tommy Tsang Cheung
Challenges in The Management of Hypertension in Asia: Bernard Man Yung Cheung and Tommy Tsang Cheung
doi:10.1093/eurheartj/sur040
Published on behalf of the European Society of Cardiology. All rights reserved. & The Author 2012.
For permissions please email: [email protected]
Hypertension is common in Asian populations and is a major cause of cardiovascular diseases. Even a small reduction in
blood pressure can lead to a substantial decrease in the risk of stroke. The prevalence of hypertension appears to be
increasing in many countries, partly because of ageing of the population, but also because of increasing obesity. While
much effort has gone into promoting the awareness of hypertension, the rates of detection, treatment, and control
remain low. As hypertension is very prevalent in the general population, it makes sense to adopt population approaches
towards the detection and treatment of hypertension, and its prevention. As obesity is a major cause of hypertension in
Asia, tackling it will help to lower the incidence of hypertension in the future. Lowering sodium contents in foods and
promotion of regular physical activity will also help to lower blood pressure at the population level. Asians appear to
respond well to calcium channel blockers but have a higher incidence of dry cough with angiotensin-converting enzyme
inhibitors.The costs of long-term follow-up and treatment impose a certain economic burden, whether on the individual
or on the health provider.
A38
China
Korea
Malaysia
Taiwan
Turkey
Year
2002
2001
1996
2002
2003
Prevalence (%)
Control (%)
Men
Women
Men
20
31.5
31.9
27.1
27.5
17
23.7
33.9
20.2
36.1
5% (total)
7.7
14.0
6.0
6.0
21.0
28.5
8.2
8.0
Women
Funding
B.M.Y.C. received funding from the Hong Kong Research
Grants Council (HKU7229/01M and HKU7626/07M) for
his work in the Hong Kong Cardiovascular Risk Factor
Prevalence Study.
Conict of interest: none declared.
References
1. Cheung BMY, Ong KL. The challenge of managing hypertension. In:
Finkel ML, ed. Public Health in the 21st Century. Santa Barbara,
CA: Praeger Publishing; 2010.
2. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J.
Global burden of hypertension: analysis of worldwide data. Lancet
2005;365:217223.
3. Cheung BM, Wat NM, Man YB, Tam S, Cheng CH, Leung GM, Woo J,
Janus ED, Lau CP, Lam TH, Lam KS. Relationship Between the Metabolic Syndrome and the Development of Hypertension in the Hong
Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2). Am J
Hypertens 2008;21:1722.
4. Cheung BM, Li MF, Ong KL, Wat NM, Tso AWK, Tam S, Pang RWC,
Thomas GN, Woo J, Janus ED, Lau CP, Lam TH, Lam KS. Raised
blood pressure and dysglycemia in Hong Kong Chinese. Diabetes
Care 2008;31:18891891.
5. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA,
Fruchart JC, James WP, Loria CM, Smith SC Jr; International Diabetes
Federation Task Force on Epidemiology and Prevention; National
Heart, Lung, and Blood Institute; American Heart Association;
World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International
Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association;
World Heart Federation; International Atherosclerosis Society; and
International Association for the Study of Obesity. Circulation 2009;
120:16401645.
6. Cheung BMY. The metabolic syndrome in China. Br J Clin Pharmacol
2006;62:260263.
7. Ramachandran A, Ma RC, Snehalatha C. Diabetes in Asia. Lancet
2010;375:408418.
8. Woo J, Cheung B, Ho SC, Sham A, Lam TH. Inuence of dietary
pattern on the development of overweight and obesity in a Chinese
population. Eur J Clin Nutr 2008;62:480487.
9. Chan JC, Cockram CS, Nicholls MG, Cheung CK, Swaminathan R. Comparison of enalapril and nifedipine in treating non-insulin dependent
diabetes associated with hypertension: one year analysis. BMJ 1992;
305:981985.
10. Woo KS, Nicholls MG. High prevalence of persistent cough with angiotensin converting enzyme inhibitors in Chinese. Br J Clin Pharmacol
1995;40:141144.
the ageing of the population and partly because of increasing obesity. We still do not know the main genes
involved and existing antihypertensive drugs are not
ideal in terms of efcacy and tolerability, resulting in imperfect compliance and suboptimal blood pressure
control. To prevent hypertension and to reduce the incidence of hypertension in the general population, lifestyle
changes, including healthy diet and regular physical activity, are of paramount importance and should be
taken up by people of all ages.